In-silico ADME Toxicity Analysis of Impurities in Commercially Marketed Δ8-THC Products for Potential Bio-medical Applications

Abstract

Background: Δ8-Tetrahydrocannabinol (Δ8-THC) is a psychoactive cannabinoid compound naturally occurring in the Cannabis sativa plant. The commercial Δ8-THC products are typically synthesized from cannabidiol (CBD), which may lead to the formation of various impurities. These impurities may contribute to unintended pharmacological or toxicological effects, highlighting the need for comprehensive safety assessment.

Purpose: This study aims to assess the pharmacokinetic and toxicity profiles of Δ8-THC and its structurally related impurities using in silico methods, thereby providing preliminary safety insights before in vitro or in vivo experimentation.

Method: In silico ADMET predictions were performed using the pkCSM web server.

Results: All analyzed compounds possess good membrane permeability and showed favorable values for intestinal absorption. The skin permeability values were within acceptable limits, with the exception of compound 10 (log Kp value -2.443). This suggests that compound 10 may have significantly reduced dermal permeability. All compounds were also predicted to exhibit high Caco-2 cell permeability. Compounds 3, 6, 7, 8, 9 (0.704, 0.542, 0.531, 0.531, 0.648), and 11 (0.227) showed relatively low VDss values. This could influence their duration of action and tissue-specific effects. All the compounds are unlikely to penetrate the blood-brain barrier (BBB), based on predicted log BB and CNS permeability indices. Our predictions indicate that impurities 6, 7, 8, 10, and 12 have the potential to inhibit the hERG channel, flagging them as possible cardiotoxic agents.

Conclusion: Δ8-THC and its structurally related impurities exhibited favorable absorption and distribution characteristics; variations in volume of distribution and dermal permeability, particularly for compound 10, may influence their pharmacological behavior. The predicted hERG inhibition by impurities 6, 7, 8, 10, and 12 raises potential cardiotoxicity concerns. Future work should include in vitro and in vivo validation of these predictions, as well as expansion to include additional impurities formed under various synthetic and storage conditions.

  • Page Number : 1-9

  • Published Date : 2025-09-30

  • Keywords
    Δ8-THC, ADMET, Cannabinoid impurities, In-silico

  • DOI Number
    10.15415/jmrh.2025.112001

  • Authors
    Munagala Alivelu and Natte Kavitha

References

  • Abdel-Kader, M. S., Radwan, M. M., Metwaly, A. M., Eissa, I. H., Hazekamp, A., & ElSohly, M. A. (2024). Chemistry and pharmacology of delta-8-tetrahydrocannabinol. Molecules (Basel, Switzerland), 29(6), 1249. https://doi.org/10.3390/molecules29061249
  • Al Azzam, K. (2022). SwissADME and pkCSM webservers predictors: An integrated online platform for accurate and comprehensive predictions for in silico ADME/T properties of artemisinin and its derivatives. Complex Use of Mineral Resources, 325(2), 14–21. https://doi.org/10.31643/2023/6445.13
  • Burrows, B. T., Watterson, L. R., Egnatios, J., & Olive, M. F. (2017). Synthetic cannabinoids: a summary of selected phenomena with respect to behavioral pharmacology and abuse liability. Handbook of Cannabis and Related Pathologies, 691-699. https://doi.org/10.1016/B978-0-12-800756-3.00082-X
  • Ekins, S., Mestres, J., & Testa, B. (2007). In silico pharmacology for drug discovery: Methods for virtual ligand screening and profiling. British Journal of Pharmacology, 152(1), 9–20. https://doi.org/10.1038/sj.bjp.0707305
  • ElSohly, M. A., Radwan, M. M., Gul, W., Chandra, S., & Galal, A. (2017). Phytochemistry of Cannabis sativa L. Progress in the Chemistry of Organic Natural Products, 103, 1–36. https://doi.org/10.1007/978-3-319-45541-9_1
  • Gallardo, A. A., Gutierrez, M. R., Gomez, L. A. J., Reyes, P. A. O. D., Dones, S. A. A., Dumbrique, M. M. U., ... & Labrador, A. M. (2024). A Comparative Analysis on the Potential Anticancer Properties of Tetrahydrocannabinol, Cannabidiol, and Tetrahydrocannabivarin Compounds Through In Silico Approach. Asian Pacific journal of cancer prevention: APJCP, 25(3), 839. https://doi.org/10.31557/APJCP.2024.25.3.839
  • Gleeson, M. P., Hersey, A., Montanari, D., & Overington, J. (2011). Probing the links between in vitro potency, ADMET and physicochemical parameters. Nature Reviews Drug Discovery, 10(3), 197–208. https://doi.org/10.1038/nrd3367
  • Gul, W., Shahzadi, I., Sarma, N., Kim, N.-C., & ElSohly, M. A. (2024). Development and validation of a GC-FID method for the quantitation of Δ8-THC and impurities found in synthetic Δ8-THC and vaping products. Planta Medica, 90(4), 316–332. https://doi.org/10.1055/a-2249-7824
  • Holt, A. K., Poklis, J. L., & Peace, M. R. (2022). ∆ 8-THC, THC-O acetates and CBD-di-O acetate: emerging synthetic cannabinoids found in commercially sold plant material and gummy edibles. Journal of Analytical Toxicology, 46(8), 940-948. https://doi.org/10.1093/jat/bkac036
  • Klimoszek, D., Jeleń, M., Dołowy, M., & Morak-Młodawska, B. (2024). Study of the lipophilicity and ADMET parameters of new anticancer diquinothiazines with pharmacophore substituents. Pharmaceuticals (Basel), 17(6), 725. https://doi.org/10.3390/ph17060725
  • Li, A. P. (2001). Screening for human ADME/Tox drug properties in drug discovery. Drug Discovery Today, 6(7), 357–366. https://doi.org/10.1016/S1359-6446(01)01712-3
  • Limban, C., Nuță, D. C., Chiriță, C., Negreș, S., Arsene, A. L., Goumenou, M., Karakitsios, S. P., Tsatsakis, A. M., & Sarigiannis, D. A. (2018). The use of structural alerts to avoid the toxicity of pharmaceuticals. Toxicology Reports, 5, 943–953. https://doi.org/10.1016/j.toxrep.2018.08.017
  • Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
  • Mathialagan, S., Chung, G., Pye, K., Rodrigues, A. D., Varma, M. V. S., & Brown, C. (2024). Significance of organic anion transporter 2 and organic cation transporter 2 in creatinine clearance: Mechanistic evaluation using freshly prepared human primary renal proximal tubule cells. Journal of Pharmacology and Experimental Therapeutics, 388(1), 201–208. https://doi.org/10.1124/jpet.123.001890
  • Meehan-Atrash, J., & Rahman, I. (2022). Novel Δ8-tetrahydrocannabinol vaporizers contain unlabeled adulterants, unintended byproducts of chemical synthesis, and heavy metals. Chemical Research in Toxicology, 35(1), 73–76. https://doi.org/10.1021/acs.chemrestox.1c00388
  • Pires, D. E., Blundell, T. L., & Ascher, D. B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
  • pkCSM Prediction Server. BioSig Lab, University of Melbourne. http://biosig.unimelb.edu.au/pkcsm/prediction.
  • Radwan, M. M., Wanas, A. S., Gul, W., Ibrahim, E. A., & ElSohly, M. A. (2023). Isolation and characterization of impurities in commercially marketed Δ8-THC products. Journal of Natural Products, 86(4), 822–829. https://doi.org/10.1021/acs.jnatprod.2c01008
  • Raies, A. B., & Bajic, V. B. (2016). In silico toxicology: Computational methods for the prediction of chemical toxicity. Wiley Interdisciplinary Reviews: Computational Molecular Science, 6(2), 147–172. https://doi.org/10.1002/wcms.1240
  • Van de Waterbeemd, H., & Gifford, E. (2003). ADMET in silico modelling: Towards prediction paradise? Nature Reviews Drug Discovery, 2(3), 192–204. https://doi.org/10.1038/nrd1032
  • Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1), 103–141. https://doi.org/10.1016/j.pharmthera.2012.12.007
  • Zhang, R., Wen, H., Lin, Z., Li, B., & Zhou, X. (2025). Artificial intelligence driven drug toxicity prediction: Advances, challenges, and future directions. Toxics, 13(7), 525. https://doi.org/10.3390/toxics13070525